Omolola Salako

896 total citations
50 papers, 429 citations indexed

About

Omolola Salako is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Omolola Salako has authored 50 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 11 papers in Public Health, Environmental and Occupational Health and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Omolola Salako's work include Global Cancer Incidence and Screening (13 papers), Advances in Oncology and Radiotherapy (9 papers) and Palliative Care and End-of-Life Issues (8 papers). Omolola Salako is often cited by papers focused on Global Cancer Incidence and Screening (13 papers), Advances in Oncology and Radiotherapy (9 papers) and Palliative Care and End-of-Life Issues (8 papers). Omolola Salako collaborates with scholars based in Nigeria, United States and United Kingdom. Omolola Salako's co-authors include Paul Okediji, Kehinde S. Okunade, Omolara Fatiregun, Nofisat Ismaila, Rose Anorlu, Esther O. Oluwole, Alero Ann Roberts, Arifullah Mohammed, Matthew Allsop and A T Onajole and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cochrane Database of Systematic Reviews.

In The Last Decade

Omolola Salako

44 papers receiving 418 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Omolola Salako 208 130 83 63 55 50 429
Heidy N. Medina 173 0.8× 63 0.5× 87 1.0× 84 1.3× 32 0.6× 30 388
J. Leonard Lichtenfeld 282 1.4× 114 0.9× 44 0.5× 62 1.0× 63 1.1× 24 679
Vincent Renard 291 1.4× 80 0.6× 80 1.0× 94 1.5× 37 0.7× 62 592
Jeanne Murphy 185 0.9× 80 0.6× 158 1.9× 95 1.5× 34 0.6× 28 617
Bridget A. Oppong 262 1.3× 111 0.9× 27 0.3× 55 0.9× 72 1.3× 49 518
Richard Lee 328 1.6× 66 0.5× 76 0.9× 57 0.9× 40 0.7× 11 453
Richard A. Hajek 364 1.8× 114 0.9× 112 1.3× 81 1.3× 26 0.5× 32 708
Chalachew Alemayehu 86 0.4× 151 1.2× 46 0.6× 61 1.0× 76 1.4× 10 381
Rebeca Franco 243 1.2× 102 0.8× 74 0.9× 118 1.9× 51 0.9× 39 580
Rebecca J. Bergin 234 1.1× 105 0.8× 21 0.3× 82 1.3× 61 1.1× 40 404

Countries citing papers authored by Omolola Salako

Since Specialization
Citations

This map shows the geographic impact of Omolola Salako's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omolola Salako with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omolola Salako more than expected).

Fields of papers citing papers by Omolola Salako

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omolola Salako. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omolola Salako. The network helps show where Omolola Salako may publish in the future.

Co-authorship network of co-authors of Omolola Salako

This figure shows the co-authorship network connecting the top 25 collaborators of Omolola Salako. A scholar is included among the top collaborators of Omolola Salako based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omolola Salako. Omolola Salako is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Salako, Omolola, Muhammad Habeebu, Paul Okediji, et al.. (2025). A systematic review and meta-analysis of side effects influenced by non-surgical treatments in African cancer patients. Supportive Care in Cancer. 33(4). 356–356.
3.
Balogun, Onyinye, Omolola Salako, Omoruyi Credit Irabor, et al.. (2024). Development and implementation of a 3d-HDR brachytherapy program for cervical cancer in a sub-Saharan African centre. Brachytherapy. 24(2). 258–264.
5.
Spencer, Katie, Kate Absolom, Matthew Allsop, et al.. (2023). Fixing the Leaky Pipe: How to Improve the Uptake of Patient-Reported Outcomes–Based Prognostic and Predictive Models in Cancer Clinical Practice. JCO Clinical Cancer Informatics. 7(7). e2300070–e2300070. 7 indexed citations
6.
Salako, Omolola, Susan Miesfeldt, Mamsau Ngoma, et al.. (2023). Remote Symptom Monitoring to Enhance the Delivery of Palliative Cancer Care in Low-Resource Settings: Emerging Approaches from Africa. International Journal of Environmental Research and Public Health. 20(24). 7190–7190. 1 indexed citations
7.
Biddanda, Arjun, Olajumoke Adeniji-Popoola, Aminu Yakubu, et al.. (2023). Whole-genome sequencing across 449 samples spanning 47 ethnolinguistic groups provides insights into genetic diversity in Nigeria. Cell Genomics. 3(9). 100378–100378. 3 indexed citations
8.
Habeebu, Muhammad, et al.. (2022). A Dosimetric Comparison of Volumetric Modulated Arc Therapy and Intensity Modulated Radiotherapy in Patients Treated with Post-Mastectomy Radiotherapy. SHILAP Revista de lepidopterología. 19(1). 92–98. 2 indexed citations
10.
Salako, Omolola, et al.. (2021). A review of breast cancer pathology reports in Nigeria. ecancermedicalscience. 15. 1190–1190. 1 indexed citations
11.
Salako, Omolola, et al.. (2021). Cancer pain control in a Nigerian Oncology Clinic: treating the disease and not the patient. Pan African Medical Journal. 40. 104–104. 4 indexed citations
12.
Salako, Omolola, et al.. (2021). Chemotherapy induced neutropenia and febrile neutropenia among breast cancer patients in a tertiary hospital in Nigeria. ecancermedicalscience. 15. 1188–1188. 9 indexed citations
13.
Fatiregun, Omolara, et al.. (2020). 10-Year Mortality Pattern Among Cancer Patients in Lagos State University Teaching Hospital, Ikeja, Lagos. Frontiers in Oncology. 10. 573036–573036. 20 indexed citations
14.
15.
Onakoya, Adeola, et al.. (2019). Ocular manifestations of leukaemia: A teaching hospital experience. Nigerian Postgraduate Medical Journal. 26(4). 205–205. 6 indexed citations
16.
Okunade, Kehinde S., et al.. (2018). Comparative analysis of serum trace element levels in women with invasive cervical cancer in Lagos, Nigeria. Pan African Medical Journal. 31. 194–194. 19 indexed citations
17.
Salako, Omolola, Paul Okediji, Muhammad Habeebu, et al.. (2018). The pattern of comorbidities in cancer patients in Lagos, South-Western Nigeria. ecancermedicalscience. 12. 843–843. 13 indexed citations
18.
Salako, Omolola, et al.. (2018). Prevalence and pattern of late-stage presentation in women with breast and cervical cancers in Lagos University Teaching Hospital, Nigeria. Nigerian Medical Journal. 59(6). 74–74. 33 indexed citations
19.
Okediji, Paul, et al.. (2017). Pattern and Predictors of Unmet Supportive Care Needs in Cancer Patients. Cureus. 9(5). e1234–e1234. 78 indexed citations
20.
Salako, Omolola, et al.. (2007). Use of search engines for research by postgraduate students of the University of Ibadan, Nigeria. African Journal of Library Archives and Information Science. 17(2). 103–117. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026